Parabilis Medicines Inc (PBLS)

Parabilis Medicines Inc (PBLS) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2026-06-30
기간	3개월
Revenues	0.15
	51.03
Research and Development	39.38
Depreciation and Amortization	0.60
Operating Income/Loss	-50.89
Nonoperating Income/Loss	-1.58
	-52.46
Attributable To Parent	-52.46
Available To Common Stockholders, Basic	-66.96
Basic Average Shares	28.91
Diluted Average Shares	28.91
Basic Earnings Per Share	-2.32
Diluted Earnings Per Share	-2.32